US Cosmetics Modernization Bill Relaunched, Now With Fragrance Allergen Labeling, PFAS Ban
Executive Summary
The Personal Care Products Safety Act was reintroduced in the US Senate on 17 June with industry support including leading brands at big-name multinationals. The latest “Feinstein bill” for modernizing US cosmetics regulations purports to strengthen counterfeit product protections while floating additional requirements for fragrance allergen labeling and banning intentionally added PFAS.
You may also be interested in...
Anti-Counterfeiting INFORM Consumers Act Cheered By Personal Care, Consumer Health Industries
The Personal Care Products Council and the Consumer Healthcare Products Association say the INFORM Consumers Act’s inclusion in US Congress’ December 2022 omnibus spending package is a win for consumers and industry.
Senate HELP Floats Draft For US Cosmetics Reform; Top Trade Groups Hustle To Respond
Bundled within the draft FDA Safety and Landmark Enhancements Act are federal cosmetics reform provisions that would require facility registration and product listings with the US FDA, adverse event reporting and good manufacturing practices, while empowering the agency to order product recalls, access company records, and suspend dangerous operations.
California Bill Could Target PFAS In Cosmetics, Intentionally Used Or Not
AB 2771, introduced in February, would ban the manufacture or sale of cosmetic products containing PFAS beginning on 1 January 2025, and it does not specify intentionally added PFAS versus those present as contaminants.